REDUCE-IT Analysis Outlines Benefit of Icosapent Ethyl Across Range of LDL-C Levels
A new analysis of the REDUCE-IT trial reveals the benefits of icosapent ethyl in reducing cardiovascular outcomes regardless of LDL-C levels.
Source: hcplive.com
Analyses Show News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Analyses Show. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Analyses Show Today - Breaking & Trending Today